31,591 Shares of GE HealthCare Technologies Inc. $GEHC Purchased by Edgestream Partners L.P.

Edgestream Partners L.P. acquired a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) in the 3rd quarter, HoldingsChannel reports. The firm acquired 31,591 shares of the company’s stock, valued at approximately $2,065,000.

A number of other hedge funds also recently added to or reduced their stakes in GEHC. State Street Corp grew its stake in shares of GE HealthCare Technologies by 1.6% in the 2nd quarter. State Street Corp now owns 20,861,566 shares of the company’s stock valued at $1,335,349,000 after purchasing an additional 323,090 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC raised its stake in shares of GE HealthCare Technologies by 13.2% during the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 13,455,814 shares of the company’s stock worth $861,307,000 after purchasing an additional 1,571,226 shares during the last quarter. Van ECK Associates Corp raised its stake in shares of GE HealthCare Technologies by 4.1% during the second quarter. Van ECK Associates Corp now owns 4,482,631 shares of the company’s stock worth $286,933,000 after purchasing an additional 177,028 shares during the last quarter. Trian Fund Management L.P. lifted its holdings in shares of GE HealthCare Technologies by 76,194.4% during the second quarter. Trian Fund Management L.P. now owns 3,085,344 shares of the company’s stock worth $197,493,000 after purchasing an additional 3,081,300 shares during the period. Finally, Perpetual Ltd lifted its holdings in shares of GE HealthCare Technologies by 107.4% during the third quarter. Perpetual Ltd now owns 2,712,232 shares of the company’s stock worth $177,299,000 after purchasing an additional 1,404,683 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms recently weighed in on GEHC. Citigroup lifted their price objective on shares of GE HealthCare Technologies from $71.00 to $79.00 and gave the company a “neutral” rating in a research report on Thursday, October 29th. Weiss Ratings upgraded shares of GE HealthCare Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, October 6th. Barclays upped their price objective on shares of GE HealthCare Technologies from $85.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, October 29th. JPMorgan Chase & Co. raised their target price on shares of GE HealthCare Technologies from $70.00 to $80.00 and gave the stock a “neutral” rating in a research note on Thursday, October 29th. Finally, Wolfe Research assumed coverage on shares of GE HealthCare Technologies in a report on Tuesday, October 20th. They issued a “peer perform” rating on the stock. Twelve equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $82.52.

Get Our Latest Report on GE HealthCare Technologies

GE HealthCare Technologies Trading Down 1.6%

Shares of GEHC opened at $80.54 on Friday. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77. The company has a current ratio of 1.30, a quick ratio of 1.01 and a debt-to-equity ratio of 0.86. The firm has a market capitalization of $36.42 billion, a P/E ratio of 16.99, a PEG ratio of 2.09 and a beta of 0.65. The firm’s 50-day moving average is $72.19 and its two-hundred day moving average is $70.19.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its quarterly earnings results on Wednesday, October 28th. The company reported $1.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.20 by $0.14. The company had revenue of $5.51 billion during the quarter, compared to the consensus estimate of $5.35 billion. GE HealthCare Technologies had a net margin of 9.96% and a return on equity of 20.45%. The company’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same period last year, the firm earned $1.07 EPS. On average, research analysts predict that GE HealthCare Technologies Inc. will post 5.02 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 13th. Investors of record on Friday, October 23rd were paid a $0.04 dividend. This represents a $0.16 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend was Friday, October 23rd. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.38%.

GE HealthCare Technologies Company Profile

(Free Report)

GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.

Featured Articles

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.